11
Axon Q2 Earnings Loom: Your Winning Stock Playbook
Axon Enterprise (AXON) Q2 2026 Earnings Preview: What You Need to Know
TL;DR: Axon reports earnings on August 5th after market close. Analysts expect revenue to jump ~30% but earnings per share to dip ~11% year-over-year. The stock has crushed the market lately (+22.5% in 6 months), but it’s very expensive (P/E ~169x). Zacks says: wait for a better entry point.
When Is the Report?
- Date: August 5, 2026
- Time: After the market closes (after 4:00 PM ET)
- Ticker: AXON (NASDAQ)
The Headline Numbers (Analyst Estimates)
| Metric | Q2 2026 Estimate | Year-Ago Quarter | Change |
|---|---|---|---|
| Revenue | $868.4 million | ~$668.5 million | +29.9% |
| Earnings Per Share (EPS) | $1.89 | ~$2.12 | -10.9% |
ELI5: "Revenue" = total money coming in the door. "EPS" = profit split per share. Revenue is growing fast, but profit per share is expected to shrink a bit.
Earnings Track Record (Last 4 Quarters)
Axon has been hit-or-miss lately:
- Beat estimates: 2 quarters
- Missed estimates: 2 quarters
- Average surprise: +8.8% (they usually do a little better than expected)
Last quarter (Q1 2026): Reported $1.61 EPS vs. $1.66 expected → missed by 3%.
Will They Beat This Time? (Zacks Prediction Model)
Zacks uses two signals to predict beats:
| Signal | Status | What It Means |
|---|---|---|
| Earnings ESP (Expected Surprise Prediction) | 0.00% | Consensus estimate ($1.89) = Most Accurate estimate ($1.89). No edge here. |
| Zacks Rank | #3 (Hold) | Not a "Strong Buy" or "Buy." Neutral rating. |
Bottom line: The model does NOT conclusively predict a beat this quarter.
[!IMPORTANT]
Key Takeaway: When ESP is 0% and Rank is #3, the odds of a positive surprise are no better than a coin flip. Don’t bet the farm on a beat.
What’s Driving the Business? (The Good Stuff)
Axon has two main engines. Both are firing.
1. Connected Devices Segment (~$479M expected, +27.4% YoY)
- TASER 10 → Strong demand for the latest energy weapon
- Cartridges → Recurring revenue (like razors & blades)
- Axon Body 4 → Next-gen body camera winning fans
- VR Training → Cops training in virtual reality
- Counter-drone tech → Growing niche, Axon is a player
2. Software & Services Segment (~$390M expected, +33.6% YoY)
- New users & devices joining the Axon network
- Digital evidence management → Cloud storage for police video/data
- Premium add-ons → AI features, analytics, workflow tools
- Recurring revenue → High-margin, sticky, predictable
Bonus: The Carbyne Acquisition (Feb 2026)
- Bought Carbyne = cloud 911 call-center tech
- Created "Axon 911" = integrates 911 calls directly into Axon’s ecosystem
- Connects callers responders instantly
- Expected to boost top line this quarter
What Could Go Wrong? (The Not-So-Good Stuff)
| Headwind | Impact |
|---|---|
| Integration costs | Merging Carbyne isn’t free |
| Higher wages | Talent is expensive |
| Stock-based compensation | Non-cash but real dilution |
| General OpEx creep | Scaling costs money |
Translation: Revenue is growing fast, but costs are growing too → margins (profit %) under pressure near-term.
Stock Price Context: How Has AXON Done Lately?
| Period | AXON | Industry (Aero/Defense) | S&P 500 | Kratos (KTOS) | Leonardo DRS (DRS) |
|---|---|---|---|---|---|
| 6 Months | +22.5% | -1.1% | +8.5% | -49% | +20.2% |
Axon has crushed peers and the broad market.
Valuation: The Elephant in the Room
| Company | Forward P/E (Price-to-Earnings) |
|---|---|
| Axon (AXON) | 169.05x |
| Industry Average | 40.35x |
| Kratos (KTOS) | 68.49x |
| Leonardo DRS (DRS) | 32.43x |
ELI5: P/E Ratio = "How many years of current earnings to pay back the stock price?"
- At 169x, you’re paying for ~169 years of today’s earnings.
- Industry average is ~40 years.
- Axon is priced for perfection. Any stumble → stock could drop fast.
[!WARNING]
Valuation Risk: This is the #1 reason Zacks says be careful. Great company ≠ great stock at any price.
Investment Thesis (The 30-Second Version)
| Bull Case | Bear Case |
|---|---|
| TASER 10 + Body 4 = product cycle tailwinds | Operating costs rising fast |
| Software recurring revenue growing 33%+ | Stock-based comp dilutes shareholders |
| Carbyne acquisition = new 911 moat | P/E 169x = priced for flawless execution |
| Counter-drone & VR = optionality | Near-term margin pressure |
| Ecosystem lock-in = high switching costs | Zacks Rank #3 (Hold), ESP 0% |
Zacks Verdict: Strong business, expensive stock. Existing holders → hold. New buyers → wait for earnings + pullback.
Summary Checklist
- Earnings date: August 5, after close
- Expect: Big revenue beat (~+30%), slight EPS dip (~-11%)
- Track record: 50/50 beat/miss last 4 quarters
- Zacks prediction: No clear signal for beat (ESP 0%, Rank #3)
- Growth drivers: TASER 10, Body 4, Software, Carbyne, Counter-drone
- Risks: Costs, integration, stock comp, valuation (169x P/E)
- Price action: +22.5% in 6 months (crushing peers)
- Recommendation: Wait for better entry post-earnings
FAQ (Questions You Might Have)
1. What does "Earnings ESP" mean in plain English?
It’s Zacks’ proprietary metric comparing the consensus estimate (what most analysts think) vs. the most accurate estimate (from analysts with the best track record). If they differ, there’s an "edge." Here, they’re identical ($1.89), so ESP = 0%. No edge detected.
2. Why is EPS expected to drop if revenue is soaring?
Because Axon is investing heavily: Carbyne integration, hiring, stock comp, R&D. Growth costs money now for profits later. The market usually rewards this if the growth keeps coming.
3. Is a P/E of 169x always bad?
Not always. For a high-growth, recurring-revenue, moat-widening company, premium multiples can persist. But it leaves zero margin for error. One missed quarter → multiple compression → stock down 20%+ fast.
4. Should I buy before earnings?
Zacks says no. The risk/reward isn’t favorable with ESP 0%, Rank #3, and nosebleed valuation. Wait for the print, then reassess.
5. What’s the "Axon Ecosystem" and why does it matter?
It’s hardware (TASER, cameras) + software (Evidence.com, AI, 911) + training (VR) + network effects. Once a police department is on Axon, switching is a nightmare. High retention + expansion revenue = compounding machine.
Final Thought
Axon is a genuinely great company with sticky products, a widening moat, and massive tailwinds (police modernization, tech adoption, public safety funding).
But the stock price already knows this. At 169x earnings, you’re paying for the next decade of perfection.
Smart play: Put it on your watchlist. Set alerts for August 5th. Read the actual report. If they beat and guide well and the stock pulls back 10-15% → that’s your entry.
Data sourced from Zacks Investment Research. This article is for informational purposes only and does not constitute financial advice. Always do your own research or consult a licensed advisor before investing.
